Rapid Antimicrobial Susceptibility Testing Shows No Clear Benefit in Gram-Negative Bacteremia
Rapid antimicrobial susceptibility testing of blood cultures is not superior to standard testing in patients with gram-negative bloodstream infections, according to the FAST trial.
